# Principia BioPharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/principia-biopharma

- Industry: Pharmaceuticals
- Headquarters: South San Francisco, US
- Website: www.principiabio.com
- Total disclosed funding: $90M
- Latest round: Series B (Jul 21, 2015)
- Investors on record: 6

## About

Founded in 2008 and based in California, US, Principia BioPharma Inc. is a biopharmaceutical company that utilizes the Tailored Covalency platform to design and develop small molecules for oral therapies to treat patients with cancer, autoimmune and inflammatory diseases.

## Funding rounds

- Series B, Jul 21, 2015, $15M — Morgenthaler Ventures
- Series B, Apr 22, 2014, $50M — Morgenthaler Ventures, OrbiMed Advisors, Sofinnova Investments, SR One, New Leaf Venture Partners, Mission Bay Capital
- Series A, Jul 1, 2012, $13M — Morgenthaler Ventures, OrbiMed Advisors, SR One, New Leaf Venture Partners, Mission Bay Capital
- Series A, Feb 10, 2011, $12M — Morgenthaler Ventures, OrbiMed Advisors, SR One, New Leaf Venture Partners, Mission Bay Capital

## Investors

- Morgenthaler Ventures (https://capitalatlas.ai/funds/morgenthaler-ventures) — Series A, Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A, Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series A, Series B
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series A, Series B
- Mission Bay Capital (https://capitalatlas.ai/funds/mission-bay-capital) — Series A, Series B
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series B